Angiodynamics (ANGO) Market Capitalization (2010 - 2026)

Angiodynamics (ANGO) has reported Market Capitalization for 17 consecutive years, with $478.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 14.49% year-over-year to $478.7 million; the trailing twelve-month figure through May 2026 stood at $478.7 million (up 14.49% YoY), and the FY2026 full-year result was $478.7 million, up 14.49% from the prior year.
• Market Capitalization steadied at $478.7 million in Q2 2026 per ANGO's latest filing, from $476.8 million in the prior quarter.
• Across five years, Market Capitalization topped out at $921.2 million in Q1 2022 and bottomed at $221.9 million in Q1 2024.
• Historically, Market Capitalization has averaged $460.4 million across 5 years, with a median of $421.7 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization slumped 63.05% in 2023, then jumped 82.17% in 2025.
• Over 5 years, Market Capitalization stood at $511.6 million in 2022, then plunged by 48.66% to $262.7 million in 2023, then increased by 7.74% to $283.0 million in 2024, then surged by 82.17% to $515.5 million in 2025, then fell by 7.14% to $478.7 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $478.7 million, $476.8 million, and $515.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.